Citation: Nikolaos Giormezis, Konstantinos Papakonstantinou, Fevronia Kolonitsiou, Eleanna Drougka, Antigoni Foka, Styliani Sarrou, Evangelos D. Anastassiou, Efthimia Petinaki, Iris Spiliopoulou. Biofilm synthesis and its relationship with genetic characteristics in clinical methicillin-resistant staphylococci[J]. AIMS Bioengineering, 2015, 2(4): 375-386. doi: 10.3934/bioeng.2015.4.375
[1] | Chiara Ceresa, Maurizio Rinaldi, Letizia Fracchia . Synergistic activity of antifungal drugs and lipopeptide AC7 against Candida albicans biofilm on silicone. AIMS Bioengineering, 2017, 4(2): 318-334. doi: 10.3934/bioeng.2017.2.318 |
[2] | Martin Hessling, Tobias Meurle, Katharina Hoenes . Surface disinfection with white-violet illumination device. AIMS Bioengineering, 2022, 9(2): 93-101. doi: 10.3934/bioeng.2022008 |
[3] | Letizia Fracchia, Jareer J. Banat, Massimo Cavallo, Chiara Ceresa, Ibrahim M. Banat . Potential therapeutic applications of microbial surface-active compounds. AIMS Bioengineering, 2015, 2(3): 144-162. doi: 10.3934/bioeng.2015.3.144 |
[4] | Chiara Ceresa, Francesco Tessarolo, Devid Maniglio, Iole Caola, Giandomenico Nollo, Maurizio Rinaldi, Letizia Fracchia . Inhibition of Candida albicans biofilm by lipopeptide AC7 coated medical-grade silicone in combination with farnesol. AIMS Bioengineering, 2018, 5(3): 192-208. doi: 10.3934/bioeng.2018.3.192 |
[5] | Sara R Robertson, Robert JC McLean . Beneficial biofilms. AIMS Bioengineering, 2015, 2(4): 437-448. doi: 10.3934/bioeng.2015.4.437 |
[6] | Wiebke Wesseling . Beneficial biofilms in marine aquaculture? Linking points of biofilm formation mechanisms in Pseudomonas aeruginosa and Pseudoalteromonas species. AIMS Bioengineering, 2015, 2(3): 104-125. doi: 10.3934/bioeng.2015.3.104 |
[7] | Amreeta Sarjit, Sin Mei Tan, Gary A. Dykes . Surface modification of materials to encourage beneficial biofilm formation. AIMS Bioengineering, 2015, 2(4): 404-422. doi: 10.3934/bioeng.2015.4.404 |
[8] | Joe A. Lemire, Marc A. Demeter, Iain George, Howard Ceri, Raymond J. Turner . A novel approach for harnessing biofilm communities in moving bed biofilm reactors for industrial wastewater treatment. AIMS Bioengineering, 2015, 2(4): 387-403. doi: 10.3934/bioeng.2015.4.387 |
[9] | Lucie Semenec, Ashley E Franks . Delving through electrogenic biofilms: from anodes to cathodes to microbes. AIMS Bioengineering, 2015, 2(3): 222-248. doi: 10.3934/bioeng.2015.3.222 |
[10] | Arindam Mitra, Suman Mukhopadhyay . Biofilm mediated decontamination of pollutants from the environment. AIMS Bioengineering, 2016, 3(1): 44-59. doi: 10.3934/bioeng.2016.1.44 |
Bacterial infections caused by the genus Staphylococcus are of great importance for human health. Coagulase-positive staphylococci are mainly represented by S. aureus, a pathogen that can cause a broad range of infections, including skin infections, pneumonia and bacteraemia [1]. Coagulase-negative staphylococci (CNS), especially S. epidermidis, have emerged as a significant health problem in hospital settings during the past decades. CNS are part of the normal skin flora but can cause severe infections, especially in immunocompromised patients or those with prosthetic devices, such as intravascular catheters or biomaterials [2].
Staphylococci express resistance to many antimicrobials used for infection treatment, an increasing problem around the globe, especially among nosocomial pathogens [3]. The introduction of methicillin and other semi-synthetic penicillins such as oxacillin and penicillinase-resistant methicillin in 1959 represented a significant step in antistaphylococcal therapy. However, the first report on methicillin resistance was published shortly after, in 1961 [4]. Today, methicillin-resistant staphylococci represent a major health problem around the globe.
Of great importance in the initiation of staphylococcal infections is the ability of these bacteria to adhere to various surfaces, such as host tissues and prosthetic devices and, subsequently, to form biofilm, which is a microbial-derived sessile community with cells attached to a substratum, interface, or to each other [5]. Bacterial cells in biofilms are embedded in a matrix of extracellular polymeric substances they produced and exhibit an altered phenotype with respect to growth rate and gene transcription [5]. In staphylococci, biofilm formation is often mediated by the production of a polysaccharide intercellular adhesin (PIA), encoded by the ica operon [6].
The first step in biofilm formation is bacterial attachment to a surface. Initial attachment is promoted by adhesins grouped into a single family, named Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) [7]. Staphylococcal adhesins are encoded by a number of genes such as fnbA (fibronectin binding protein A) [8], sasG (S. aureus surface protein G) [9], aap (accumulation associated protein) [10], fbe (fibrinogen binding protein epidermidis) [11] and bhp (Bap homologue protein of S. epidermidis) [12]. S. aureus fibronectin-binding protein A (FnbA) possesses multiple regions capable of conferring adherence to both soluble and immobilized forms of fibronectin. Thus, S. aureus is able to invade endothelial cells both in vivo and in vitro. FnbA also promotes bacterial attachment to fibrinogen and adherence and aggregation of activated platelets [8]. SasG has been identified as another adherence factor for nasal epithelium cells [13]. However, it does not exhibit adherence ability for major extracellular matrices such as fibronectin or fibrinogen, suggesting that this protein is a unique adhesin involved in the intercellular aggregation of S. aureus.
A highly homologous to SasG protein has also been identified in S. epidermidis. Aap is a 220 kDa protein which acts as a polysaccharide-independent mechanism of S. epidermidis biofilm accumulation and intercellular adhesion [10]. Fbe, another member of the MSCRAMM family found in S. epidermidis, is similar to the clumping factor of S. aureus [14]. Moreover, bhp in S. epidermidis encodes a cell-wall associated protein, similar to the biofilm-associated protein Bap of S. aureus [12]. This protein is implicated in biofilm formation, even in ica-negative staphylococci [15].
The aim of the present study was to investigate possible differences in biofilm forming ability, antimicrobial resistance patterns and genetic background of methicillin-resistant S. aureus and S. epidermidis isolated in a University Hospital in Greece. Clonal distribution and the frequency of ica and adhesin-encoding genes, as well as, their contribution to biofilm formation were also determined.
A total of 321 staphylococci from different patients hospitalized in a tertiary-care teaching hospital in Greece (University General Hospital of Patras, UGHP), during an one-year period (1st July 2010 till 30th June 2011) were selected to be further analyzed. One hundred and six S. aureus strains were recovered from skin and soft tissue infections (SSTIs), broncheal aspirations (BAs) nasal carriage (NC), and bloodstream infections (BSIs). One hundred and forty-five S. epidermidis, 58 S. haemolyticus, ten S. hominis and two S. lugdunensis were recovered from patients with BSIs defined by established criteria (clinical symptoms and two or more positive blood cultures within two days apart) [16] or prosthetic device-associated infections (PDAIs, patients with intravascular catheters, local signs of infection and ≥15 cfu in semi-quantitative catheter culture).
Staphylococci were identified to species level by the Vitek 2 Advanced Expert System (bioMerieux, Marcy l'Etoile, France) and by restriction fragment length polymorphism analysis of the amplified tuf gene [17]. Susceptibility to cefoxitin (FOX), erythromycin (E), clindamycin (CC), kanamycin (KAN), tobramycin (NN), gentamicin (GM), ciprofloxacin (CIP), fusidic acid (FA) and sulfamethoxazole/ trimethoprim (SXT) was tested by the disk diffusion method according to EUCAST guidelines [18]. MICs of oxacillin (OX), vancomycin (VA), teicoplanin (TEC), linezolid (LNZ) and daptomycin (DAP) were determined by E-test (bioMerieux). Isolates resistant to at least three different classes of antimicrobials were considered multidrug resistant. Biofilm formation was tested by the quantitative assay in microtiter plates using the reference S. epidermidis ATCC35984 (RP62A, biofilm-positive /ica-positive) and ATCC12228 (biofilm-negative/ica-negative) strains, as positive and negative controls respectively [19]. Beta-lactamase production was tested by nitrocefin assay (Becton Dickinson, Franklin Lakes, New Jersey, USA).
Amplification of mecA, two genes of the ica operon (icaA, icaD) in all staphylococci and the adhesin-encoding genes sasG and fnbA in S. aureus, as well as, aap, fbe and bhp in S. epidermidis, was performed by PCR with specific primers as previously described [13,20,21,22,23,24,25,26]. PCR products were analyzed by electrophoresis into 1% agarose gels.
Staphylococci were classified into pulsotypes by Pulsed-Field Gel Electrophoresis (PFGE) of chromosomal DNA after digestion with the restriction enzyme SmaI [27]. A dendrogram comparing molecular weights of DNA fragments was performed by FPQuest software version 4.5 (Bio-Rad Laboratories Inc). Patterns differing by less than 79% (corresponding to a difference of less than seven bands) were considered to belong to the same PFGE type [28]. Ninety selected strains of the main S. aureus and S. epidermidis PFGE types were characterized by Multilocus Sequence Typing (MLST) (http://mlst.net). Results were analyzed by the application of eBURST algorithm. Clonal complexes were defined by using the default setting, in which all STs within a clonal complex differed by no more than one allele from at least one other ST in the clonal complex.
Pearson’s chi-square test and Fisher’s exact test were used to evaluate differences in the frequencies of variables among tested strains, conducted by IBM SPSS Statistics version 20 (SPSS, Inc., Chicago, IL). Isolates were assorted according to species, origin, biofilm formation and clone distribution. Results were considered statistically significant at a P-value < 0.05.
Studied isolates (321) comprised five species: S. aureus (106 strains), S. epidermidis (145), S. haemolyticus (58), S. hominis (10) and S. lugdunensis (2). The majority of S. aureus strains (75/106, 70.8%) derived from SSTIs (wounds and abscesses), eighteen (17%) from BSIs, five (4.7%) from NC and eight (7.5%) from BAs. S. epidermidis isolates were recovered from BSIs (70/145, 48.3%) and PDAIs (75/145, 51.7%). Twenty nine S. haemolyticus, five S. hominis and one S. lugdunensis were also recovered from BSIs, whereas, the remaining isolates derived from PDAIs.Twelve S. aureus, 82 S. epidermidis, 30 S. haemolyticus, five S. hominis and one S. lugdunensis were recovered from children.
All staphylococci were cefoxitin- and oxacillin-resistant carrying mecA gene. All isolates were susceptible to daptomycin (MICs 0.064-1 mg/L), teicoplanin and vancomycin (MICs 0.25-2 mg/L for S. aureus and 0.25-4 mg/L for CNS). Eight S. epidermidis were resistant to linezolid (MICs 16-256 mg/L). The majority of tested staphylococci (304/321, 94.7%) were multi-resistant. MRSE and the other MR-CNS expressed higher resistance rates to antimicrobials than MRSA and were more frequently multi-resistant (Table 1). The non-epidermidis MR-CNS expressed higher resistance rates to kanamycin, gentamicin, ciprofloxacin and SXT as compared to MRSE. However, no significant difference in beta lactamase production was identified (Table 1).
MRSA N=106 (%) | MRSE N=145 (%) | MR-CNS N=70 (%) | Pa-value | Pb-value | Pc-value | |
Beta lactamase | 102 (96.2) | 134 (92.4) | 66 (94.3) | 0.284 | 0.199 | 0.778 |
Multi-drug resistance | 93 (87.7) | 142 (97.9) | 69 (98.6) | 0.001 | 0.009 | 1.000 |
Clindamycin resistance | 32 (30.2) | 127 (87.6) | 64 (91.4) | <0.001 | <0.001 | 0.493 |
Erythromycin resistance | 61 (57.5) | 137 (94.5) | 69 (98.6) | <0.001 | <0.001 | 0.277 |
Kanamycin resistance | 96 (90.6) | 123 (84.8) | 67 (95.7) | 0.250 | 0.249 | 0.022 |
Tobramycin resistance | 51 (48.1) | 131 (90.3) | 67 (95.7) | <0.001 | <0.001 | 0.280 |
Gentamicin resistance | 22 (20.8) | 106 (73.1) | 64 (91.4) | <0.001 | <0.001 | 0.002 |
Ciprofloxacin resistance | 17 (16) | 98 (67.6) | 65 (92.9) | <0.001 | <0.001 | <0.001 |
Fusidic acid resistance | 76 (71.7) | 133 (91.7) | 66 (94.3) | <0.001 | <0.001 | 0.590 |
Sulfamethoxazole/ trimethoprim resistance | 24 (22.6) | 108 (74.5) | 64 (91.4) | <0.001 | <0.001 | 0.003 |
Biofilm formation | 19 (17.9) | 71 (49) | 31 (44.3) | <0.001 | <0.001 | 0.562 |
ica in total | 72 (67.9) | 120 (82.8) | 27 (38.6) | 0.007 | <0.001 | <0.001 |
ica in biofilm (+) | 13/19 (68.4) | 65/71 (91.5) | 12/31 (38.7) | 0.017 | 0.079 | <0.001 |
ica in biofilm (-) | 59/87 (67.8) | 55/74 (74.3) | 15/39 (38.5) | 0.389 | 0.003 | <0.001 |
aComparison between MRSA and MRSE, bComparison between MRSA and MR-CNS, cComparison between MRSE and MR-CNS. |
S. aureusisolates were less PFGE diverse, with five pulsotypes and, among them, one major PFGE type (C) consisting of 77/106 strains (72.6%). MLST data revealed five sequence types: ST5, ST30, ST80, ST225 and ST239. The main type, ST80, included the majority (97.4%) of PFGE type (C) isolates. Analysis with eBURST algorithm showed that identified STs belonged to three clonal groups (CC1 includes ST5, ST225 and ST239, whereas, CC2 and CC14 include ST30 and ST80, respectively). According to susceptibility results, type (C) strains were less resistant to clindamycin, erythromycin, gentamicin and sulfamethoxazole/trimethoprim as compared to the other pulsotypes.
PFGE typing revealed a diverse MRSE population; one hundred and forty five S. epidermidis were grouped in 52 PFGE types including two main pulsotypes (type a included 48, whereas, type b 34 strains) that comprised 56.6% of the studied S. epidermidis population (82 out of 145 strains). Among the S. epidermidis strains, three major sequence types were identified: ST2, ST5 and ST16. The main PFGE pulsotype (a) was characterized as ST2, whereas, type (b) strains belonged to ST5 and ST16 (59.6% and 40.4%, respectively). Analysis with eBURST software showed that all three STs belonged to the same clonal complex (CC2), with ST2 being the primary group founder. Type (a) strains displayed a higher resistance rate to clindamycin, kanamycin, tobramycin, gentamicin, ciprofloxacin, fusidic acid and sulfamethoxazole/trimethoprim as compared to pulsotype (b) (P < 0.05, Table 2). Among the non-epidermidis MR-CNS a variety of PFGE types was characterized; 12 clones were identified in S. haemolyticus, eight in S. hominis and two in S. lugdunensis. One major PFGE type (h) prevailed in S. haemolyticus population, including 44/58 isolates. No difference in the antimicrobial resistance rates between type h and the other PFGE types was identified, except for sulfamethoxazole/ trimethoprim (P = 0.040, Table 2).
S. aureus | S. epidermidis | S. haemolyticus | |||||||
PFGE types | Type C N=77 (%) | Others N=29 (%) | P-value | Type a N=48 (%) | Type b N=34 (%) | P-value | Type h N=44 (%) | Others N=14 (%) | P-value |
Beta lactamase | 75 (97.4) | 27 (93.1) | 0.301 | 45 (93.8) | 30 (88.2) | 0.441 | 44 (100) | 14 (100) | - |
Clindamycin resistance | 11 (14.3) | 21 (72.4) | <0.001 | 46 (95.8) | 26 (76.5) | 0.014 | 42 (95.5) | 12 (85.7) | 0.243 |
Erythromycin resistance | 22 (28.6) | 23 (79.3) | <0.001 | 46 (95.8) | 32 (94.1) | 1.000 | 43 (97.7) | 14 (100) | 1.000 |
Kanamycin resistance | 73 (94.8) | 23 (79.3) | 0.024 | 47 (97.9) | 23 (67.6) | <0.001 | 43 (97.7) | 14 (100) | 1.000 |
Tobramycin resistance | 38 (49.4) | 13 (44.8) | 0.828 | 47 (97.9) | 28 (82.4) | 0.018 | 43 (97.7) | 13 (92.9) | 0.428 |
Gentamicin resistance | 6 (7.8) | 16 (55.2) | <0.001 | 45 (93.8) | 16 (47.1) | <0.001 | 42 (95.5) | 13 (92.9) | 1.000 |
Ciprofloxacin resistance | 12 (15.6) | 5 (17.2) | 1.000 | 48 (100) | 20 (58.8) | <0.001 | 43 (97.7) | 12 (85.7) | 0.142 |
Fusidic acid resistance | 57 (74) | 19 (65.5) | 0.469 | 47 (97.9) | 28 (82.4) | 0.018 | 42 (95.5) | 12 (85.7) | 0.243 |
Sulfamethoxazole/ trimethoprim resistance | 5 (6.5) | 19 (65.5) | <0.001 | 47 (97.9) | 17 (50) | <0.001 | 43 (97.7) | 11 (78.6) | 0.040 |
Biofilm formation | 15 (19.5) | 4 (13.8) | 0.582 | 22 (45.8) | 16 (47.1) | 1.000 | 20 (45.5) | 8 (57.1) | 0.545 |
ica | 52 (67.5) | 20 (69) | 1.000 | 46 (95.8) | 25 (73.5) | 0.006 | 17 (38.6) | 3 (21.4) | 0.338 |
sasG | 51 (66.2) | 20 (69) | 1.000 | - | - | - | - | - | - |
fnbA | 68 (88.3) | 19 (65.5) | 0.010 | - | - | - | - | - | - |
aap | - | - | - | 22 (45.8) | 23 (67.6) | 0.072 | - | - | - |
fbe | - | - | - | 42 (87.5) | 32 (94.1) | 0.459 | - | - | - |
In total, 121 out of 321 staphylococcal isolates (37.7%) produced biofilm (19 S. aureus, 71 S. epidermidis, 28 S. haemolyticus and three S. hominis) whereas, 219 (68.2%) carried ica operon. MRSE prevailed in biofilm formation and ica carriage. In particular, 19/106 (17.9%) MRSA, 71/145 (49%) MRSE and 31/70 (44.3%) MR-CNS produced biofilm. The presence of ica operon was more frequent in MRSE (Pa = 0.007 and Pc < 0.001, Table 1). The majority of MRSA and MRSE carried at least one adhesin gene. In total, 96/106 (90.6%) MRSA carried sasG, fnbA or both genes and 131/145 (90.3%) MRSE carried at least one of the genes aap, fbe, or bhp.No difference in the adhesin gene carriage between MRSA and MRSE was identified, in biofilm-positive (P = 0.674) or biofilm-negative (P = 0.795) isolates. In MRSA, 56/72 (77.8%) ica-positive isolates carried sasG, whereas 66/120 (55%) ica-positive MRSE carried aap.
There is a statistically significant difference between biofilm producers and non-producers with regards to ica operon carriage, in favor of the biofilm-positive isolates, among the S. epidermidis population (91.5% vs 74.3%, P= 0.008, Table 3). S. epidermidis belonging to pulsotype (a) also showed a higher rate of ica operon carriage as compared to strains of type (b) (95.8% vs 73.5%, P = 0.006). Among MRSE isolates, fbe and aap were detected in the majority of strains tested (121/145, 83.4% and 79/145, 54.5%, respectively). Ten isolates carried aap but not fbe and only two produced biofilm. Three MRSE that were aap-positive and did not carry ica or fbe did not produce biofilm either. On the contrary, bhp was detected in only 38/145 (26.2%) MRSE. No significant difference between biofilm-positive and biofilm-negative isolates was found concerning the adhesin genes carriage (P > 0.05, Table 3). In MRSE, isolates from BSIs prevailed in biofilm formation (58.6% vs 40%, P= 0.031), whereas, strains from PDAIs carried more frequently aap (66.7% vs 41.4%, P= 0.003).
MRSA | MRSE | |||||||||
Biofilm (+) N=19 (%) | Biofilm (-) N=87 (%) | P-value | Biofilm (+) N=71 (%) | Biofilm (-) N=74 (%) | P-value | |||||
ica | 13 (68.4) | 59 (67.8) | 1.000 | ica | 65 (91.5) | 55 (74.3) | 0.008 | |||
sasG | 11 (57.9) | 60 (69) | 0.422 | aap | 40 (56.3) | 39 (52.7) | 0.739 | |||
fnbA | 16 (84.2) | 71 (81.6) | 1.000 | fbe | 63 (88.7) | 58 (78.4) | 0.119 | |||
bhp | 14 (19.7) | 24 (32.4) | 0.092 |
FnbA was the predominant adhesin among MRSA and specifically in type (C) (P = 0.010, Table 2), whereas, sasG was also detected in the majority of isolates. Nine MRSA carried sasG without fnbA and only one was biofilm-positive. One isolate was sasG-positive but did not carry ica or fnbA and it did not produce biofilm. No difference related to the origin of MRSA isolates was identified regarding biofilm formation, ica and adhesin genescarriage.
S. aureus is an important aetiological agent of human infections including skin and soft tissue infections, endocarditis, osteomyelitis and septic arthritis. It colonises the skin and mucosa of humans and several animal species, especially the anterior nares of the nose [29]. Coagulase-negative staphylococci, especially S. epidermidis, are also frequent part of the human flora, but can emerge as pathogens in patients with low immune response or foreign bodies, particularly prosthetic cardiac valves, cerebrospinal fluid shunts, intravascular catheters and orthopaedic implants [2]. In our collection of methicillin-resistant staphylococci, MRSA were isolated mainly from skin and soft tissue infections and bacteraemias, whereas, MR-CNS were recovered from BSIs and PDAIs.
The increasing resistance rate of staphylococci to antimicrobials has been frequently reported [3].In our study, all isolates were methicillin-resistant, but a high prevalence of multidrug resistance was also identified. MRSE and MR-CNS were more frequently multi-resistant as compared to MRSA. MR-CNS isolates were also associated with higher resistance rates to all antimicrobialstested, in accordance with previously published data [3]. Among MRSE, resistance was associated with clone distribution. In particular, PFGE type (a) (ST2) expressed higher resistance rates to clindamycin, aminoglycosides, ciprofloxacin, fusidic acid and sulfamethoxazole/trimethoprim, as compared to type (b) (ST5 and ST16). In S. aureus, the main PFGE type C was less resistant as compared to other pulsotypes, with the exception of kanamycin. In spite of the high resistance level, all staphylococci were susceptible to vancomycin, teicoplanin and daptomycin. However, identification of vancomycin MICs of 2 mg/L in S. aureus and 4 mg/L in S. epidermidis often renders the use of this antibiotic inefficient.
S. aureus isolates showed a comparatively low level of genetic diversity, with one major PFGE type (C) consisting of 77/106 strains (72.6%). MLST analysis concluded that there was one major sequence type, ST80, which included the majority (97.4%) of PFGE type (C) isolates. In a 12-year survey of MRSA infections in six hospitals in Greece, ST80 predominated and infiltrated the hospital settings in the period 2001-2012, successfully replacing other clones [1]. Predominance of ST239 was also reported [1]. ST239 was also one of the five clones identified in our S. aureus collection.
Although polyclonality was observed among S. epidermidis, sequence types ST2, ST5 and ST16 predominated in this study. All three clones belong to the same clonal complex, CC2. ST2 has been identified as a major clone in previous epidemiologic studies [30]. A collection of S. epidermidis isolates from various sources including blood cultures and catheter tips from patients in Germany was analyzed by MLST by Mertens et al and ST2 was found to be the predominant one [31]. One major PFGE type (h) prevailed in the S. haemolyticus population, including 44/58 isolates. This clone was associated with high resistance rate to sulfamethoxazole/ trimethoprim. PFGE type h has also been identified in previous epidemiologic studies in Greece [24].
A major factor in the pathogenesis of staphylococcal infections is biofilm formation [5]. Both S. aureus and S. epidermidis display a strong capacity to form biofilms [32]. Biofilm development involves the initial attachment, accumulation/maturation and detachment. The prevalent mechanism of Staphylococcus biofilm accumulation is linked to the synthesis of PIA, encoded by the ica operon [6]. In our study, biofilm formation was directly associated with ica operon carriage in MRSE, since biofilm-positive isolates carried ica operon in a statistically higher percentage (91.5%) as compared to biofilm-negative MRSE (74.3%, P = 0.008).
To become a pathogen, staphylococci have to gain access to the human host usually by adhering to biotic surfaces, such as components of the extracellular matrix or host tissue, or to abiotic surfaces, such as medical devices. Upon adherence, bacteria colonize and proliferate on the respective biotic or abiotic surface by forming a biofilm [33]. Primary attachment to a biotic surface in host tissues and synthetic surfaces coated with plasma proteins, such as fibronectin, fibrinogen and vitronectin is mediated by adhesins like S. aureus’ fibronectin-binding protein A (FnbA) and S. epidermidis’ fibrinogen-binding protein Fbe. The Bhp protein promotes the bacterial primary attachment to abiotic surfaces, as well as intercellular adhesion during biofilm formation [34]. In our collection of staphylococci, fnbA and fbe were identified in the majority of isolates, whereas, sasG, aap and bhp were detected to a lesser extent. No relation between the origin of the isolate and gene carriage was found. However, fnbA carriage was related with clonal distribution, as it was mainly found in the major PFGE type C.
S. aureus colonizes the moist squamous epithelium of the anterior nares. One of the adhesins likely to be responsible is its surface protein G (SasG), which has sequence similarity with the protein Aap (accumulation associated protein) of S. epidermidis [35]. Aap can promote either the primary attachment or accumulation phase of biofilm formation. Most isolates in our study carried sasG or aap. In MRSE, aap was more prevalent in strains from PDAIs. Patel et al used an in vitro model to demonstrate that enhanced expression of aap and ica genes plays an important role in initial foreign body colonization and potentially in the establishment of a device-associated S. epidermidis infection [36].
Even though no clonal relationship was found concerning biofilm formation, a statistically significant difference for ica and fnbA gene carriage in favour of specific clones was identified. The main S. aureus clone ST80 was significantly related with fnbA carriage.
Certain S. aureus, S. epidermidis and S. haemolyticus clones predominate in patients with various staphylococcal infections. The majority of methicillin-resistant isolates in our study was multidrug resistant and carried ica and adhesin-encoding genes, whereas, biofilm formation was mainly identified in S. epidermidis and non-epidermidis CNS isolates. Specific staphylococcal phenotypic and genotypic characteristics combined with successful clonal expansion render these bacteria important pathogens in hospital settings.
The Ethics Committee of the University Hospital of Patras approved this study and waived the need for informed consent (Approval No: 316).
This research was partially supported by funding of the National Staphylococcal Reference Laboratory, Greece, under the scientific responsibility of I. S. and E.D.A. (grant C954, Hellenic Centre for Disease Control and Prevention, HCDCP/KEELPNO).
E.D. and A.F. have received financial support from the National Staphylococcal Reference Laboratory, Greece.
[1] |
Drougka E, Foka A, Liakopoulos A, et al. (2014) A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic? Clin Microbiol Infect 20: O796-803. doi: 10.1111/1469-0691.12624
![]() |
[2] |
McCann MT, Gilmore BF, Gorman SP (2008) Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm Pharmacol 60: 1551-1571. doi: 10.1211/jpp.60.12.0001
![]() |
[3] |
Santos Sanches I, Mato R, de Lencastre H, et al. (2000) Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb Drug Resist 6: 199-211. doi: 10.1089/mdr.2000.6.199
![]() |
[4] |
Hiramatsu K, Cui L, Kuroda M, et al. (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9: 486-493. doi: 10.1016/S0966-842X(01)02175-8
![]() |
[5] |
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. doi: 10.1128/CMR.15.2.167-193.2002
![]() |
[6] | Mack D, Fischer W, Krokotsch A, et al. (1996) The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 178: 175-183. |
[7] |
Tristan A, Ying L, Bes M, et al. (2003) Use of multiplex PCR to identify Staphylococcus aureus adhesins involved in human hematogenous infections. J Clin Microbiol 41: 4465-4467. doi: 10.1128/JCM.41.9.4465-4467.2003
![]() |
[8] |
Edwards AM, Potts JR, Josefsson E, et al. (2010) Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog 6: e1000964. doi: 10.1371/journal.ppat.1000964
![]() |
[9] |
Kuroda M, Ito R, Tanaka Y, et al. (2008) Staphylococcus aureus surface protein SasG contributes to intercellular autoaggregation of Staphylococcus aureus. Biochem Biophys Res Commun 377: 1102-1106. doi: 10.1016/j.bbrc.2008.10.134
![]() |
[10] |
Rohde H, Burdelski C, Bartscht K, et al. (2005) Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol 55: 1883-1895. doi: 10.1111/j.1365-2958.2005.04515.x
![]() |
[11] |
Arciola CR, Campoccia D, Gamberini S, et al. (2004) Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections. Biomaterials 25: 4825-4829. doi: 10.1016/j.biomaterials.2003.11.056
![]() |
[12] |
Bowden MG, Chen W, Singvall J, et al. (2005) Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 151: 1453-1464. doi: 10.1099/mic.0.27534-0
![]() |
[13] |
Roche FM, Meehan M, Foster TJ (2003) The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 149: 2759-2767. doi: 10.1099/mic.0.26412-0
![]() |
[14] |
Hartford O, O'Brien L, Schofield K, et al. (2001) The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. Microbiology 147: 2545-2552. doi: 10.1099/00221287-147-9-2545
![]() |
[15] |
Tormo MA, Knecht E, Gotz F, et al. (2005) Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology 151: 2465-2475. doi: 10.1099/mic.0.27865-0
![]() |
[16] |
Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36: 309-332. doi: 10.1016/j.ajic.2008.03.002
![]() |
[17] |
Kontos F, Petinaki E, Spiliopoulou I, et al. (2003) Evaluation of a novel method based on PCR Restriction Fragment Length Polymorphism Analysis of the tuf gene for the identification of Staphylococcus species. J Microbiol Methods 55: 465-469. doi: 10.1016/S0167-7012(03)00173-8
![]() |
[18] | The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014. http://www.eucast.org. |
[19] |
Stepanovic S, Vukovic D, Hola V, et al. (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115: 891-899. doi: 10.1111/j.1600-0463.2007.apm_630.x
![]() |
[20] | Murakami K, Minamide W, Wada K, et al. (1991) Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 29: 2240-2244. |
[21] |
Cafiso V, Bertuccio T, Santagati M, et al. (2004) Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production. Clin Microbiol Infect 10: 1081-1088. doi: 10.1111/j.1469-0691.2004.01024.x
![]() |
[22] |
Gomes AR, Vinga S, Zavolan M, et al. (2005) Analysis of the genetic variability of virulence-related loci in epidemic clones of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49: 366-379. doi: 10.1128/AAC.49.1.366-379.2005
![]() |
[23] |
Vandecasteele SJ, Peetermans WE, R RM, et al. (2003) Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 9: 114-119. doi: 10.1046/j.1469-0691.2003.00544.x
![]() |
[24] |
Giormezis N, Kolonitsiou F, Foka A, et al. (2014) Coagulase-negative staphylococcal bloodstream and prosthetic-device-associated infections: the role of biofilm formation and distribution of adhesin and toxin genes. J Med Microbiol 63: 1500-1508. doi: 10.1099/jmm.0.075259-0
![]() |
[25] | Potter A, Ceotto H, Giambiagi-Demarval M, et al. (2009) The gene bap, involved in biofilm production, is present in Staphylococcus spp. strains from nosocomial infections. J Microbiol 47: 319-326. |
[26] |
Sandoe JA, Longshaw CM (2001) Ventriculoperitoneal shunt infection caused by Staphylococcus lugdunensis. Clin Microbiol Infect 7: 385-387. doi: 10.1046/j.1198-743x.2001.00268.x
![]() |
[27] | Tenover FC, Arbeit RD, Goering RV, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239. |
[28] |
Miragaia M, Carrico JA, Thomas JC, et al. (2008) Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition. J Clin Microbiol 46: 118-129. doi: 10.1128/JCM.01685-07
![]() |
[29] |
Wertheim HF, Melles DC, Vos MC, et al. (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5: 751-762. doi: 10.1016/S1473-3099(05)70295-4
![]() |
[30] |
Liakopoulos A, Spiliopoulou I, Damani A, et al. (2010) Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J Antimicrob Chemother 65: 1070-1071. doi: 10.1093/jac/dkq065
![]() |
[31] |
Mertens A, Ghebremedhin B (2013) Genetic determinants and biofilm formation of clinical Staphylococcus epidermidis isolates from blood cultures and indwelling devises. Eur J Microbiol Immunol (Bp) 3: 111-119. doi: 10.1556/EuJMI.3.2013.2.4
![]() |
[32] | Speziale P, Pietrocola G, Foster TJ, et al. (2014) Protein-based biofilm matrices in Staphylococci. Front Cell Infect Microbiol 4: 171. |
[33] | Linke DGA (2011) Bacterial Adhesion. Chemistry, Biology and Physics: Springer Netherlands. 374 p. |
[34] |
Cucarella C, Solano C, Valle J, et al. (2001) Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 183: 2888-2896. doi: 10.1128/JB.183.9.2888-2896.2001
![]() |
[35] |
Corrigan RM, Rigby D, Handley P, et al. (2007) The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 153: 2435-2446. doi: 10.1099/mic.0.2007/006676-0
![]() |
[36] | Patel JD, Colton E, Ebert M, et al. (2012) Gene expression during S. epidermidis biofilm formation on biomaterials. J Biomed Mater Res A 100: 2863-2869. |
1. | Maria Plota, Eleni Sazakli, Nikolaos Giormezis, Foteini Gkartziou, Fevronia Kolonitsiou, Michalis Leotsinidis, Sophia G. Antimisiaris, Iris Spiliopoulou, In Vitro Anti-Biofilm Activity of Bacteriophage K (ATCC 19685-B1) and Daptomycin against Staphylococci, 2021, 9, 2076-2607, 1853, 10.3390/microorganisms9091853 |
MRSA N=106 (%) | MRSE N=145 (%) | MR-CNS N=70 (%) | Pa-value | Pb-value | Pc-value | |
Beta lactamase | 102 (96.2) | 134 (92.4) | 66 (94.3) | 0.284 | 0.199 | 0.778 |
Multi-drug resistance | 93 (87.7) | 142 (97.9) | 69 (98.6) | 0.001 | 0.009 | 1.000 |
Clindamycin resistance | 32 (30.2) | 127 (87.6) | 64 (91.4) | <0.001 | <0.001 | 0.493 |
Erythromycin resistance | 61 (57.5) | 137 (94.5) | 69 (98.6) | <0.001 | <0.001 | 0.277 |
Kanamycin resistance | 96 (90.6) | 123 (84.8) | 67 (95.7) | 0.250 | 0.249 | 0.022 |
Tobramycin resistance | 51 (48.1) | 131 (90.3) | 67 (95.7) | <0.001 | <0.001 | 0.280 |
Gentamicin resistance | 22 (20.8) | 106 (73.1) | 64 (91.4) | <0.001 | <0.001 | 0.002 |
Ciprofloxacin resistance | 17 (16) | 98 (67.6) | 65 (92.9) | <0.001 | <0.001 | <0.001 |
Fusidic acid resistance | 76 (71.7) | 133 (91.7) | 66 (94.3) | <0.001 | <0.001 | 0.590 |
Sulfamethoxazole/ trimethoprim resistance | 24 (22.6) | 108 (74.5) | 64 (91.4) | <0.001 | <0.001 | 0.003 |
Biofilm formation | 19 (17.9) | 71 (49) | 31 (44.3) | <0.001 | <0.001 | 0.562 |
ica in total | 72 (67.9) | 120 (82.8) | 27 (38.6) | 0.007 | <0.001 | <0.001 |
ica in biofilm (+) | 13/19 (68.4) | 65/71 (91.5) | 12/31 (38.7) | 0.017 | 0.079 | <0.001 |
ica in biofilm (-) | 59/87 (67.8) | 55/74 (74.3) | 15/39 (38.5) | 0.389 | 0.003 | <0.001 |
aComparison between MRSA and MRSE, bComparison between MRSA and MR-CNS, cComparison between MRSE and MR-CNS. |
S. aureus | S. epidermidis | S. haemolyticus | |||||||
PFGE types | Type C N=77 (%) | Others N=29 (%) | P-value | Type a N=48 (%) | Type b N=34 (%) | P-value | Type h N=44 (%) | Others N=14 (%) | P-value |
Beta lactamase | 75 (97.4) | 27 (93.1) | 0.301 | 45 (93.8) | 30 (88.2) | 0.441 | 44 (100) | 14 (100) | - |
Clindamycin resistance | 11 (14.3) | 21 (72.4) | <0.001 | 46 (95.8) | 26 (76.5) | 0.014 | 42 (95.5) | 12 (85.7) | 0.243 |
Erythromycin resistance | 22 (28.6) | 23 (79.3) | <0.001 | 46 (95.8) | 32 (94.1) | 1.000 | 43 (97.7) | 14 (100) | 1.000 |
Kanamycin resistance | 73 (94.8) | 23 (79.3) | 0.024 | 47 (97.9) | 23 (67.6) | <0.001 | 43 (97.7) | 14 (100) | 1.000 |
Tobramycin resistance | 38 (49.4) | 13 (44.8) | 0.828 | 47 (97.9) | 28 (82.4) | 0.018 | 43 (97.7) | 13 (92.9) | 0.428 |
Gentamicin resistance | 6 (7.8) | 16 (55.2) | <0.001 | 45 (93.8) | 16 (47.1) | <0.001 | 42 (95.5) | 13 (92.9) | 1.000 |
Ciprofloxacin resistance | 12 (15.6) | 5 (17.2) | 1.000 | 48 (100) | 20 (58.8) | <0.001 | 43 (97.7) | 12 (85.7) | 0.142 |
Fusidic acid resistance | 57 (74) | 19 (65.5) | 0.469 | 47 (97.9) | 28 (82.4) | 0.018 | 42 (95.5) | 12 (85.7) | 0.243 |
Sulfamethoxazole/ trimethoprim resistance | 5 (6.5) | 19 (65.5) | <0.001 | 47 (97.9) | 17 (50) | <0.001 | 43 (97.7) | 11 (78.6) | 0.040 |
Biofilm formation | 15 (19.5) | 4 (13.8) | 0.582 | 22 (45.8) | 16 (47.1) | 1.000 | 20 (45.5) | 8 (57.1) | 0.545 |
ica | 52 (67.5) | 20 (69) | 1.000 | 46 (95.8) | 25 (73.5) | 0.006 | 17 (38.6) | 3 (21.4) | 0.338 |
sasG | 51 (66.2) | 20 (69) | 1.000 | - | - | - | - | - | - |
fnbA | 68 (88.3) | 19 (65.5) | 0.010 | - | - | - | - | - | - |
aap | - | - | - | 22 (45.8) | 23 (67.6) | 0.072 | - | - | - |
fbe | - | - | - | 42 (87.5) | 32 (94.1) | 0.459 | - | - | - |
MRSA | MRSE | |||||||||
Biofilm (+) N=19 (%) | Biofilm (-) N=87 (%) | P-value | Biofilm (+) N=71 (%) | Biofilm (-) N=74 (%) | P-value | |||||
ica | 13 (68.4) | 59 (67.8) | 1.000 | ica | 65 (91.5) | 55 (74.3) | 0.008 | |||
sasG | 11 (57.9) | 60 (69) | 0.422 | aap | 40 (56.3) | 39 (52.7) | 0.739 | |||
fnbA | 16 (84.2) | 71 (81.6) | 1.000 | fbe | 63 (88.7) | 58 (78.4) | 0.119 | |||
bhp | 14 (19.7) | 24 (32.4) | 0.092 |
MRSA N=106 (%) | MRSE N=145 (%) | MR-CNS N=70 (%) | Pa-value | Pb-value | Pc-value | |
Beta lactamase | 102 (96.2) | 134 (92.4) | 66 (94.3) | 0.284 | 0.199 | 0.778 |
Multi-drug resistance | 93 (87.7) | 142 (97.9) | 69 (98.6) | 0.001 | 0.009 | 1.000 |
Clindamycin resistance | 32 (30.2) | 127 (87.6) | 64 (91.4) | <0.001 | <0.001 | 0.493 |
Erythromycin resistance | 61 (57.5) | 137 (94.5) | 69 (98.6) | <0.001 | <0.001 | 0.277 |
Kanamycin resistance | 96 (90.6) | 123 (84.8) | 67 (95.7) | 0.250 | 0.249 | 0.022 |
Tobramycin resistance | 51 (48.1) | 131 (90.3) | 67 (95.7) | <0.001 | <0.001 | 0.280 |
Gentamicin resistance | 22 (20.8) | 106 (73.1) | 64 (91.4) | <0.001 | <0.001 | 0.002 |
Ciprofloxacin resistance | 17 (16) | 98 (67.6) | 65 (92.9) | <0.001 | <0.001 | <0.001 |
Fusidic acid resistance | 76 (71.7) | 133 (91.7) | 66 (94.3) | <0.001 | <0.001 | 0.590 |
Sulfamethoxazole/ trimethoprim resistance | 24 (22.6) | 108 (74.5) | 64 (91.4) | <0.001 | <0.001 | 0.003 |
Biofilm formation | 19 (17.9) | 71 (49) | 31 (44.3) | <0.001 | <0.001 | 0.562 |
ica in total | 72 (67.9) | 120 (82.8) | 27 (38.6) | 0.007 | <0.001 | <0.001 |
ica in biofilm (+) | 13/19 (68.4) | 65/71 (91.5) | 12/31 (38.7) | 0.017 | 0.079 | <0.001 |
ica in biofilm (-) | 59/87 (67.8) | 55/74 (74.3) | 15/39 (38.5) | 0.389 | 0.003 | <0.001 |
aComparison between MRSA and MRSE, bComparison between MRSA and MR-CNS, cComparison between MRSE and MR-CNS. |
S. aureus | S. epidermidis | S. haemolyticus | |||||||
PFGE types | Type C N=77 (%) | Others N=29 (%) | P-value | Type a N=48 (%) | Type b N=34 (%) | P-value | Type h N=44 (%) | Others N=14 (%) | P-value |
Beta lactamase | 75 (97.4) | 27 (93.1) | 0.301 | 45 (93.8) | 30 (88.2) | 0.441 | 44 (100) | 14 (100) | - |
Clindamycin resistance | 11 (14.3) | 21 (72.4) | <0.001 | 46 (95.8) | 26 (76.5) | 0.014 | 42 (95.5) | 12 (85.7) | 0.243 |
Erythromycin resistance | 22 (28.6) | 23 (79.3) | <0.001 | 46 (95.8) | 32 (94.1) | 1.000 | 43 (97.7) | 14 (100) | 1.000 |
Kanamycin resistance | 73 (94.8) | 23 (79.3) | 0.024 | 47 (97.9) | 23 (67.6) | <0.001 | 43 (97.7) | 14 (100) | 1.000 |
Tobramycin resistance | 38 (49.4) | 13 (44.8) | 0.828 | 47 (97.9) | 28 (82.4) | 0.018 | 43 (97.7) | 13 (92.9) | 0.428 |
Gentamicin resistance | 6 (7.8) | 16 (55.2) | <0.001 | 45 (93.8) | 16 (47.1) | <0.001 | 42 (95.5) | 13 (92.9) | 1.000 |
Ciprofloxacin resistance | 12 (15.6) | 5 (17.2) | 1.000 | 48 (100) | 20 (58.8) | <0.001 | 43 (97.7) | 12 (85.7) | 0.142 |
Fusidic acid resistance | 57 (74) | 19 (65.5) | 0.469 | 47 (97.9) | 28 (82.4) | 0.018 | 42 (95.5) | 12 (85.7) | 0.243 |
Sulfamethoxazole/ trimethoprim resistance | 5 (6.5) | 19 (65.5) | <0.001 | 47 (97.9) | 17 (50) | <0.001 | 43 (97.7) | 11 (78.6) | 0.040 |
Biofilm formation | 15 (19.5) | 4 (13.8) | 0.582 | 22 (45.8) | 16 (47.1) | 1.000 | 20 (45.5) | 8 (57.1) | 0.545 |
ica | 52 (67.5) | 20 (69) | 1.000 | 46 (95.8) | 25 (73.5) | 0.006 | 17 (38.6) | 3 (21.4) | 0.338 |
sasG | 51 (66.2) | 20 (69) | 1.000 | - | - | - | - | - | - |
fnbA | 68 (88.3) | 19 (65.5) | 0.010 | - | - | - | - | - | - |
aap | - | - | - | 22 (45.8) | 23 (67.6) | 0.072 | - | - | - |
fbe | - | - | - | 42 (87.5) | 32 (94.1) | 0.459 | - | - | - |
MRSA | MRSE | |||||||||
Biofilm (+) N=19 (%) | Biofilm (-) N=87 (%) | P-value | Biofilm (+) N=71 (%) | Biofilm (-) N=74 (%) | P-value | |||||
ica | 13 (68.4) | 59 (67.8) | 1.000 | ica | 65 (91.5) | 55 (74.3) | 0.008 | |||
sasG | 11 (57.9) | 60 (69) | 0.422 | aap | 40 (56.3) | 39 (52.7) | 0.739 | |||
fnbA | 16 (84.2) | 71 (81.6) | 1.000 | fbe | 63 (88.7) | 58 (78.4) | 0.119 | |||
bhp | 14 (19.7) | 24 (32.4) | 0.092 |